These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis. Melichar B, Nash MA, Lenzi R, Platsoucas CD, Freedman RS. Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960 [Abstract] [Full Text] [Related]
5. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection. Lumsden JM, Roberts JM, Harris NL, Peach RJ, Ronchese F. J Immunol; 2000 Jan 01; 164(1):79-85. PubMed ID: 10604996 [Abstract] [Full Text] [Related]
6. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway. Ndejembi MP, Teijaro JR, Patke DS, Bingaman AW, Chandok MR, Azimzadeh A, Nadler SG, Farber DL. J Immunol; 2006 Dec 01; 177(11):7698-706. PubMed ID: 17114440 [Abstract] [Full Text] [Related]
7. Effect of CD80 and CD86 on T cell cytokine production. Petro TM, Chen SS, Panther RB. Immunol Invest; 1995 Nov 01; 24(6):965-76. PubMed ID: 8575841 [Abstract] [Full Text] [Related]
8. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway. Shanafelt MC, Kang I, Barthold SW, Bockenstedt LK. Infect Immun; 1998 Jan 01; 66(1):266-71. PubMed ID: 9423867 [Abstract] [Full Text] [Related]
9. CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy? van Gool SW, Barcy S, Devos S, Vandenberghe P, Ceuppens JL, Thielemans K, de Boer M. Res Immunol; 1995 Jan 01; 146(3):183-96. PubMed ID: 8525052 [No Abstract] [Full Text] [Related]
10. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation. Murphy EE, Terres G, Macatonia SE, Hsieh CS, Mattson J, Lanier L, Wysocka M, Trinchieri G, Murphy K, O'Garra A. J Exp Med; 1994 Jul 01; 180(1):223-31. PubMed ID: 7516409 [Abstract] [Full Text] [Related]
11. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation. Van Gool SW, Zhang Y, Kasran A, de Boer M, Ceuppens JL. Scand J Immunol; 1996 Jul 01; 44(1):21-9. PubMed ID: 8693288 [Abstract] [Full Text] [Related]
12. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation. Lin H, Wei RQ, Goodman RE, Bolling SF. Surgery; 1997 Aug 01; 122(2):129-37. PubMed ID: 9288115 [Abstract] [Full Text] [Related]
13. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways. Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, Linsley PS, Bromberg JS, Baliga P. Transplantation; 1996 Oct 15; 62(7):1011-8. PubMed ID: 8878397 [Abstract] [Full Text] [Related]
14. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile. Broeren CP, Gray GS, Carreno BM, June CH. J Immunol; 2000 Dec 15; 165(12):6908-14. PubMed ID: 11120816 [Abstract] [Full Text] [Related]
15. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins. van Wijk F, Nierkens S, de Jong W, Wehrens EJ, Boon L, van Kooten P, Knippels LM, Pieters R. J Immunol; 2007 Jun 01; 178(11):6894-900. PubMed ID: 17513738 [Abstract] [Full Text] [Related]
16. Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells. Gause WC, Urban JF, Linsley P, Lu P. Immunol Res; 1995 Jun 01; 14(3):176-88. PubMed ID: 8778208 [Abstract] [Full Text] [Related]
17. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R. Immunity; 1994 Dec 01; 1(9):793-801. PubMed ID: 7534620 [Abstract] [Full Text] [Related]
18. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura K, Lanier LL, Banchereau J. J Exp Med; 1994 Nov 01; 180(5):1841-7. PubMed ID: 7525840 [Abstract] [Full Text] [Related]
19. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. Liu Z, Geboes K, Hellings P, Maerten P, Heremans H, Vandenberghe P, Boon L, van Kooten P, Rutgeerts P, Ceuppens JL. J Immunol; 2001 Aug 01; 167(3):1830-8. PubMed ID: 11466409 [Abstract] [Full Text] [Related]
20. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions. Greene JL, Leytze GM, Emswiler J, Peach R, Bajorath J, Cosand W, Linsley PS. J Biol Chem; 1996 Oct 25; 271(43):26762-71. PubMed ID: 8900156 [Abstract] [Full Text] [Related] Page: [Next] [New Search]